“ "A key challenge we have – at Gilead but also as an industry – is how to expedite access to medicines for patients in Canada." ”
In Conversation
“ "For the first time, after many years, we have a government commitment to increase the budget allocated to research by 20 percent" ”
“ "Through Pascal Soriot’s global leadership, AstraZeneca has a robust and exciting global pipeline that we can leverage at the local level." ”
“ "Ipsen Canada has had a great start. We are somewhat of a poster child for the Ontario government now when it comes to attracting more foreign… ”
“ "The idea is to provide an integrated healthcare provision system that allows the patient to move more fluidly from home to hospital and back. The goal… ”
“ "When we are talking about addressing issues within the wider health systems, I believe all stakeholders need to be involved, and that includes industry." ”
“ Therapure President and CEO, Nick Green, speaks about the environment for contract development and manufacturing in Canada and the integrated services that Therapure can offer its… ”
“ The CEO of DelMar Pharmaceuticals discusses British Columbia’s competitive strengths in the biotechnology space, and demonstrates how his company’s therapy for glioblastoma will change the way… ”
“ John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for… ”
“ Pierre Montanaro, President and CEO of Pharmetics, discusses the history of his company’s work in the private label business and future plans to expand into a… ”
“ David Goodman, CEO of Pharmascience, describes the importance of balancing innovation with low cost products in Canada and outlines his company’s strategy for growth domestically and… ”
“ John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for… ”
